Literature DB >> 11243511

Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy.

J Comín-Colet1, M A Sánchez-Corral, J J Alegre-Sancho, J Valverde, D López-Gómez, X Sabaté, A Juan-Mas, E Esplugas.   

Abstract

Complete heart block (CHB) is a rare complication of systemic lupus erythematosus (SLE), mainly seen during an acute flare-up of the disease or after high-dose long-term treatment with antimalarial drugs, although anti-Ro and anti-RNP antibodies have also been implied by some authors. A 40-y-old woman developed CHB in the context of an acute flare-up of SLE, first diagnosed three years ago, having recently commenced hydroxychloroquine (HCQ) treatment. Anti-Ro and anti-RNP antibodies were also positive. No features of myocarditis were found. A temporary pacemaker was required and complete resolution was achieved on steroid therapy with withdrawal of antimalarial therapy. The characteristics of previous cases are well publicised and discussion focuses on the possible aetiology and pathogenesis of the present case.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243511     DOI: 10.1191/096120301673172543

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study.

Authors:  Ertao Jia; Hongling Geng; Qingping Liu; Yuya Xiao; Yanying Zhang; Jingjing Xie; Luhe Zhang; Xia Qiu; Li Zhong; Min Xiao; Jianyong Zhang
Journal:  Ir J Med Sci       Date:  2018-11-20       Impact factor: 1.568

2.  Variable atrioventricular block in systemic lupus erythematosus.

Authors:  Sybille Liautaud; Ahmed J Khan; Shireesha R Nalamasu; Irene J Tan; Anekwe E Onwuanyi
Journal:  Clin Rheumatol       Date:  2004-10-26       Impact factor: 2.980

Review 3.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

4.  Atrioventricular heart block and syncope coincident with diagnosis of systemic lupus erythematosus.

Authors:  Micah T Prochaska; Paul A Bergl; Amit R Patel; Joshua D Moss; Stephen L Archer
Journal:  Can J Cardiol       Date:  2013-08-02       Impact factor: 5.223

5.  Association of Anti-Ro/Sjögren's syndrome type A Antibodies and Complete Atrioventricular Block in an Adult With Sjögren's Syndrome.

Authors:  Weng Kin Tam; Hui Ching Hsu; Ming Hsiung Hsieh; Jong Shiuan Yeh; Weng Chio Tam
Journal:  Arch Rheumatol       Date:  2017-10-12       Impact factor: 1.472

Review 6.  Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.

Authors:  Erik A Korte; Patrick M Gaffney; David W Powell
Journal:  Arthritis Res Ther       Date:  2012-02-20       Impact factor: 5.156

7.  Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.

Authors:  Elizabeth Park; Jon T Giles; Thania Perez-Recio; Paloma Pina; Christopher Depender; Yevgeniya Gartshteyn; Anca Askanase; Joan Bathon; Laura Geraldino-Pardilla
Journal:  Res Sq       Date:  2021-06-29

8.  Clinical characteristics of lupus myocarditis in Korea.

Authors:  Jae-Wook Chung; Dai-Yeol Joe; Han-Jung Park; Hyoun-Ah Kim; Hae-Sim Park; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2007-07-19       Impact factor: 3.580

9.  Left Atrial Inexcitability in Children With Congenital Lupus-Induced Complete Atrioventricular Block.

Authors:  Sylvia Abadir; Anne Fournier; Suzanne J Vobecky; Charles V Rohlicek; Philippe Romeo; Paul Khairy
Journal:  J Am Heart Assoc       Date:  2015-12-16       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.